LA

Linda Avey

Co-founder & CEO, Precise.ly

📍 San Francisco, California, United States🔄 Updated October 2026💼 4 investments📅 2 years investing🗓 Last invested May 2025𝕏 @upgrade_to_unlock
VC🌍 United States
4
Total investments
0
Early stage
2
Mid stage
1
Late stage
2y
Years active

Portfolio

4 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
May 2025
At NextSense, we’re on a mission to restore energy, joy, and purpose in everyday life through the development of intuitive and accessible brain health technology. Eliminating exhaustion is the first step in ensuring that the brain functions at its best, so that’s where we’re starting.
Investor
Feb 2025
Stealth AI Startup is an independent initiative focused on founders building AI companies before public launch. We explore the earliest stages of building an AI startup—from testing an idea and finding collaborators to assembling a team and preparing to launch. Our focus: • Founder experiences and lessons from building in stealth • Emerging AI technologies and startup trends • Perspectives from founders, researchers, engineers and investors • Practical learning for the journey from idea to launch We believe founders can exchange knowledge and build meaningful professional connections while keeping their products and plans confidential. This is the official LinkedIn Page of the Stealth AI Startup initiative. It represents our initiative, rather than the separate companies built by founders who follow it. Following or engaging with this page does not, by itself, establish employment, partnership or endorsement. Follow us for perspectives on building AI companies and updates from our initiative. Visit us at https://www.stealthaistartup.online/
Investor
Oct 2024
Radicle Science enables health and wellness companies to generate real-world, clinical-grade evidence without the legacy costs. Through large-scale decentralized trials and AI-driven analytics, we transform how evidence is generated, moving from slow and costly studies to scalable validation that accelerates innovation, enables stronger claims, and drives market adoption. We are your partner in transparency, delivering evidence at the speed of modern innovation. This is Proof-as-a-Service.
Investor
May 2024
Unlocking the potential of macrocycle drug discovery through machine learning and massively parallel synthesis
late stageBiotechnology
Experience · 9 entries
All (9)
Investments (4)
Founder (3)
2025
Investor
May 2025
At NextSense, we’re on a mission to restore energy, joy, and purpose in everyday life through the development of intuitive and accessible brain health technology. Eliminating exhaustion is the first step in ensuring that the brain functions at its best, so that’s where we’re starting.
Investor
Feb 2025
Stealth AI Startup is an independent initiative focused on founders building AI companies before public launch. We explore the earliest stages of building an AI startup—from testing an idea and finding collaborators to assembling a team and preparing to launch. Our focus: • Founder experiences and lessons from building in stealth • Emerging AI technologies and startup trends • Perspectives from founders, researchers, engineers and investors • Practical learning for the journey from idea to launch We believe founders can exchange knowledge and build meaningful professional connections while keeping their products and plans confidential. This is the official LinkedIn Page of the Stealth AI Startup initiative. It represents our initiative, rather than the separate companies built by founders who follow it. Following or engaging with this page does not, by itself, establish employment, partnership or endorsement. Follow us for perspectives on building AI companies and updates from our initiative. Visit us at https://www.stealthaistartup.online/
2024
Investor
Oct 2024
Radicle Science enables health and wellness companies to generate real-world, clinical-grade evidence without the legacy costs. Through large-scale decentralized trials and AI-driven analytics, we transform how evidence is generated, moving from slow and costly studies to scalable validation that accelerates innovation, enables stronger claims, and drives market adoption. We are your partner in transparency, delivering evidence at the speed of modern innovation. This is Proof-as-a-Service.
Investor
May 2024
Unlocking the potential of macrocycle drug discovery through machine learning and massively parallel synthesis
late stageBiotechnology
2023
Advisor
Dec 2023
Giant backs frontier technology founders rebuilding the foundations of civilisation. We champion entrepreneurs driven by purpose and relentless ambition to advance humanity. There is a once-in-a-generation opportunity to redesign how the world works. Profound technological breakthroughs are accelerating amidst climate crisis, demographic upheaval and geopolitical revolution. Giant seeks companies reimagining foundational systems: energy, materials, industry, work, finance, biology and healthcare. We invest from first cheque to growth. From AI, robotics and automation to techbio, electrification and the future of work. Giant stands for technology as a force for good, crafted by high integrity founders.
Show all 9 entries ↓
Investment activity
2024–2025 · 4 investments
2024220252
Recent (last 2 years)Earlier